Zobrazeno 1 - 10
of 314
pro vyhledávání: '"Peraro L"'
Autor:
GERDA Collaboration, Agostini, M., Allardt, M., Andreotti, E., Bakalyarov, A. M., Balata, M., Barabanov, I., Heider, M. Barnabe, Barros, N., Baudis, L., Bauer, C., Becerici-Schmidt, N., Bellotti, E., Belogurov, S., Belyaev, S. T., Benato, G., Bettini, A., Bezrukov, L., Bode, T., Brudanin, V., Brugnera, R., Budjas, D., Caldwell, A., Cattadori, C., Chernogorov, A., Cossavella, F., Demidova, E. V., Denisov, A., Domula, A., Egorov, V., Falkenstein, R., Ferella, A. D., Freund, K., Froborg, F., Frodyma, N., Gangapshev, A., Garfagnini, A., Gazzana, S., Grambayr, P., Gurentsov, V., Gusev, K., Guthikonda, K. K., Hampel, W., Hegai, A., Heisel, M., Hemmer, S., Heusser, G., Hofmann, W., Hult, M., Inzhechik, L. V., Ioannucci, L., Csathy, J. Janicsko, Jochum, J., Junker, M., Kianovsky, S., Kirpichnikov, I. V., Kirsch, A., Klimenko, A., Knoepfle, K. T., Kochetov, O., Kornoukhov, V. N., Kusminov, V., Laubenstein, M., Lazzaro, A., Lebedev, V. I., Lehnert, B., Liao, H. Y., Lindner, M., Lippi, I., Liu, X., Lubashevskiy, A., Lubsandorzhiev, B., Lutter, G., Machado, A. A., Majorovits, B., Maneschg, W., Nemchenok, I., Nisi, S., O'Shaughnessy, C., Pandola, L., Pelczar, K., Peraro, L., Pullia, A., Riboldi, S., Ritter, F., Sada, C., Salathe, M., Schmitt, C., Schoenert, S., Schreiner, J., Schulz, O., Schwingenheuer, B., Shevchik, E., Shirchenko, M., Simgen, H., Smolnikov, A., Stanco, L., Strecker, H., Tarka, M., Ur, C. A., Vasenko, A. A., Volynets, O., von Sturm, K., Walter, M., Wegmann, A., Wojcik, M., Yanovich, E., Zavarise, P., Zhitnikov, I., Zhukov, S. V., Zinatulina, D., Zuber, K., Zuzel, G.
Publikováno v:
J. Phys. G: Nucl. Part. Phys. 40 (2013) 035110
The primary goal of the GERmanium Detector Array (Gerda) experiment at the Laboratori Nazionali del Gran Sasso of INFN is the search for the neutrinoless double beta decay of Ge-76. High-purity germanium detectors made from material enriched in Ge-76
Externí odkaz:
http://arxiv.org/abs/1212.3210
Autor:
Mun SS; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA., Meyerberg J; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA., Peraro L; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA., Korontsvit T; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA., Gardner T; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA., Malviya M; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA., Kyi C; Gynecologic Medical Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Weill Cornell Medical College, New York, NY, USA., O'Cearbhaill RE; Gynecologic Medical Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Weill Cornell Medical College, New York, NY, USA., Liu C; Eureka Therapeutics, Inc., Emeryville, CA, USA., Dao T; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA., Scheinberg DA; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA. scheinbd@mskcc.org.; Weill Cornell Medical College, New York, NY, USA. scheinbd@mskcc.org.
Publikováno v:
Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2023 Nov; Vol. 72 (11), pp. 3773-3786. Date of Electronic Publication: 2023 Aug 27.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Lam DK; Beam Therapeutics, Cambridge, MA, USA., Feliciano PR; Beam Therapeutics, Cambridge, MA, USA., Arif A; Beam Therapeutics, Cambridge, MA, USA., Bohnuud T; Beam Therapeutics, Cambridge, MA, USA., Fernandez TP; Beam Therapeutics, Cambridge, MA, USA., Gehrke JM; Beam Therapeutics, Cambridge, MA, USA., Grayson P; Beam Therapeutics, Cambridge, MA, USA., Lee KD; Beam Therapeutics, Cambridge, MA, USA., Ortega MA; Beam Therapeutics, Cambridge, MA, USA., Sawyer C; Beam Therapeutics, Cambridge, MA, USA., Schwaegerle ND; Beam Therapeutics, Cambridge, MA, USA., Peraro L; Beam Therapeutics, Cambridge, MA, USA., Young L; Beam Therapeutics, Cambridge, MA, USA., Lee SJ; Beam Therapeutics, Cambridge, MA, USA., Ciaramella G; Beam Therapeutics, Cambridge, MA, USA., Gaudelli NM; Beam Therapeutics, Cambridge, MA, USA. ngaudelli@beamtx.com.
Publikováno v:
Nature biotechnology [Nat Biotechnol] 2023 May; Vol. 41 (5), pp. 686-697. Date of Electronic Publication: 2023 Jan 09.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Caroli, D., Gubbiotti, A., Guido, E., Ancona, F., Peraro, L., Scribano, L., Polato, F., Ravagnan, P.A., Giacon, G., De Lazzari, F., Rosa Rizzotto, E.
Publikováno v:
Digestive & Liver Disease; 2024 Supplement 2, Vol. 56, pS279-S280, 2p
Autor:
Klatt MG; Molecular Pharmacology Program, Sloan Kettering Institute, New York, NY., Dao T; Molecular Pharmacology Program, Sloan Kettering Institute, New York, NY., Yang Z; Eureka Therapeutics, Emeryville, CA., Liu J; Eureka Therapeutics, Emeryville, CA., Mun SS; Molecular Pharmacology Program, Sloan Kettering Institute, New York, NY., Dacek MM; Molecular Pharmacology Program, Sloan Kettering Institute, New York, NY., Luo H; Molecular Pharmacology Program, Sloan Kettering Institute, New York, NY., Gardner TJ; Molecular Pharmacology Program, Sloan Kettering Institute, New York, NY., Bourne C; Molecular Pharmacology Program, Sloan Kettering Institute, New York, NY.; Immunology and Microbial Pathogenesis Program and., Peraro L; Molecular Pharmacology Program, Sloan Kettering Institute, New York, NY., Aretz ZEH; Molecular Pharmacology Program, Sloan Kettering Institute, New York, NY.; Physiology, Biophysics and Systems Biology Program, Weill Cornell Medicine, New York, NY., Korontsvit T; Molecular Pharmacology Program, Sloan Kettering Institute, New York, NY., Lau M; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY; and., Kharas MG; Molecular Pharmacology Program, Sloan Kettering Institute, New York, NY., Liu C; Eureka Therapeutics, Emeryville, CA., Scheinberg DA; Molecular Pharmacology Program, Sloan Kettering Institute, New York, NY.; Pharmacology Program, Weill Cornell Medicine, New York, NY.
Publikováno v:
Blood [Blood] 2022 Aug 25; Vol. 140 (8), pp. 861-874.
Autor:
Peraro L; Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Bourne CM; Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Weill Cornell Medicine, New York, NY 10065, USA., Dacek MM; Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Weill Cornell Medicine, New York, NY 10065, USA., Akalin E; Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY 10467, USA., Park JH; Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Smith EL; Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Scheinberg DA; Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Weill Cornell Medicine, New York, NY 10065, USA. Electronic address: scheinbd@mskcc.org.
Publikováno v:
Molecular therapy : the journal of the American Society of Gene Therapy [Mol Ther] 2021 Dec 01; Vol. 29 (12), pp. 3398-3409. Date of Electronic Publication: 2021 Jul 02.
Publikováno v:
Digestive & Liver Disease; 2024 Supplement 2, Vol. 56, pS210-S210, 1p